The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Eisai; Lilly; Novartis; Pfizer; PharmaMar
Research Funding - Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly; Novartis; Pfizer; PharmaMar
Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.
 
Rafael Morales-Barrera
Consulting or Advisory Role - AstraZeneca; MSD; Sanofi
Speakers' Bureau - Asofarma; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Johnson & Johnson; Lilly; MSD; Roche/Genentech; Sanofi
 
Cristina Suarez Rodriguez
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Novartis; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Pfizer; Roche/Genentech
Research Funding - AB Science (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Oncology (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Millennium (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Macarena Gonzalez
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Lilly; Lilly; Novartis; Pierre Fabre; Roche
 
Javier Ros
No Relationships to Disclose
 
Maria Eugenia Semidey
No Relationships to Disclose
 
Ester Serra Hernandez
Travel, Accommodations, Expenses - Bayer; Clovis Oncology
 
Joaquin Mateo
Consulting or Advisory Role - AstraZeneca; Janssen; Roche (Inst)
Speakers' Bureau - Astellas Pharma; AstraZeneca; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Sanofi
Other Relationship - BeiGene
 
Carlos Fernández Sáez
Travel, Accommodations, Expenses - AstraZeneca
 
Fernando Lozano
Honoraria - Nucleix
Research Funding - Nucleix (Inst)
 
Richard Mast
Travel, Accommodations, Expenses - TOSHIBA
 
Sarai Roche
No Relationships to Disclose
 
Angela Quintana
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Sara Gutiérrez Fernández
No Relationships to Disclose
 
Cesar Serrano
Honoraria - Bayer
Consulting or Advisory Role - Blueprint Medicines; Deciphera
Research Funding - Bayer; Deciphera; Pfizer
Travel, Accommodations, Expenses - Bayer; Lilly; Novartis; Pfizer; PharmaMar
 
Claudia Valverde
No Relationships to Disclose
 
Ines de Torres
No Relationships to Disclose
 
Xavier Maldonado
Consulting or Advisory Role - Bayer Health
Speakers' Bureau - Astellas Medivation; Ipsen; Janssen
Travel, Accommodations, Expenses - Astellas Medivation; Ipsen
 
Juan Morote
No Relationships to Disclose
 
Joan Carles
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Johnson & Johnson; MSD Oncology; Pfizer; Roche; Sanofi
Speakers' Bureau - Asofarma; Astellas Pharma; Bayer; Johnson & Johnson